Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of endocrine malignancies: a review.

× No keyword cloud information.

13 in total

1. Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.

Authors: Samer Ezziddin; Feras Khalaf; Maria Vanezi; Torjan Haslerud; Karin Mayer; Abdullah Al Zreiqat; Winfried Willinek; Hans-Jürgen Biersack; Amir Sabet
Journal: Eur J Nucl Med Mol Imaging Date: 2014-02-07 Impact factor: 9.236

Review 2. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors: Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal: Pituitary Date: 2006 Impact factor: 4.107

3. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.

Authors: R Arnold; M E Trautmann; W Creutzfeldt; R Benning; M Benning; C Neuhaus; R Jürgensen; K Stein; H Schäfer; C Bruns; H J Dennler
Journal: Gut Date: 1996-03 Impact factor: 23.059

4. Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestine.

Authors: Amir Sabet; Kristina Dautzenberg; Torjan Haslerud; Anas Aouf; Amin Sabet; Birgit Simon; Karin Mayer; Hans-Jürgen Biersack; Samer Ezziddin
Journal: Eur J Nucl Med Mol Imaging Date: 2015-03-26 Impact factor: 9.236

5. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

Authors: Jonathan R Strosberg; Robert L Fine; Junsung Choi; Aejaz Nasir; Domenico Coppola; Dung-Tsa Chen; James Helm; Larry Kvols
Journal: Cancer Date: 2010-09-07 Impact factor: 6.860

Review 6. Treatment of Zollinger-Ellison syndrome.

Authors: Paola Tomassetti; Davide Campana; Lydia Piscitelli; Elena Mazzotta; Emilio Brocchi; Raffaele Pezzilli; Roberto Corinaldesi
Journal: World J Gastroenterol Date: 2005-09-21 Impact factor: 5.742

Review 7. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

Authors: Paola Tomassetti; Teresa Salomone; Marina Migliori; Davide Campana; Roberto Corinaldesi
Journal: Drugs Aging Date: 2003 Impact factor: 3.923

8. Proliferative activity of neuroendocrine tumours of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigations.

Authors: A von Herbay; B Sieg; G Schürmann; W J Hofmann; M Betzler; H F Otto
Journal: Gut Date: 1991-08 Impact factor: 23.059

9. Surgical management of malignant islet cell tumors.

Authors: C S Grant
Journal: World J Surg Date: 1993 Jul-Aug Impact factor: 3.352

10. Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs.

Authors: Renata D'Alpino Peixoto; Krista L Noonan; Peter Pavlovich; Hagen F Kennecke; Howard J Lim
Journal: J Gastrointest Oncol Date: 2014-08